Résumé
Introduction: Antimicrobial-resistant HAI (Healthcare associated infection) are a global challenge due to their impact on patient outcome. Implementation of antimicrobial stewardship programmes (AMSP) is needed at institutional and national levels. Assessment of core capacities for AMSP is an important starting point to initiate nationwide AMSP. We conducted an assessment of the core capacities for AMSP in a network of Indian hospitals, which are part of the Global Health Security Agenda-funded work on capacity building for AMR-HAIs. Subjects and Methods: The Centers for Disease Control and Prevention's core assessment checklist was modified as per inputs received from the Indian network. The assessment tool was filled by twenty hospitals as a self-administered questionnaire. The results were entered into a database. The cumulative score for each question was generated as average percentage. The scores generated by the database were then used for analysis. Results and Conclusion: The hospitals included a mix of public and private sector hospitals. The network average of positive responses for leadership support was 45%, for accountability; the score was 53% and for key support for AMSP, 58%. Policies to support optimal antibiotic use were present in 59% of respondents, policies for procurement were present in 79% and broad interventions to improve antibiotic use were scored as 33%. A score of 52% was generated for prescription-specific interventions to improve antibiotic use. Written policies for antibiotic use for hospitalised patients and outpatients were present on an average in 72% and 48% conditions, respectively. Presence of process measures and outcome measures was scored at 40% and 49%, respectively, and feedback and education got a score of 53% and 40%, respectively. Thus, Indian hospitals can start with low-hanging fruits such as developing prescription policies, restricting the usage of high antibiotics, enforcing education and ultimately providing the much-needed leadership support.
Sujets)
Antibactériens/administration et posologie , Humains , Nouveau-né , Mâle , Staphylococcus aureus résistant à la méticilline/isolement et purification , Parotidite/diagnostic , Parotidite/traitement médicamenteux , Parotidite/microbiologie , Parotidite/anatomopathologie , Sialadénite/diagnostic , Sialadénite/traitement médicamenteux , Sialadénite/microbiologie , Sialadénite/anatomopathologie , Infections à staphylocoques/diagnostic , Infections à staphylocoques/traitement médicamenteux , Infections à staphylocoques/microbiologie , Infections à staphylocoques/anatomopathologie , Maladie de la glande sous-maxillaire/diagnostic , Maladie de la glande sous-maxillaire/traitement médicamenteux , Maladie de la glande sous-maxillaire/microbiologie , Maladie de la glande sous-maxillaire/anatomopathologie , Suppuration/anatomopathologie , Résultat thérapeutiqueRésumé
Emergence of multi and pan-drug resistant Gram-negative bacteria causing nosocomial infections in intensive care settings has become a challenge for clinicians. The mortality rate of ventilator-associated pneumonia (VAP) is known to increase when the initial microbiological diagnosis and antimicrobial therapy are inappropriate. We present a case of a 18-year-old man, who after being admitted following an accident, had developed VAP due to multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp. and had a downhill clinical course despite broad-spectrum antibiotic treatment. The strains were found to be Col-S, as the susceptibility was tested. Colistin was instituted, with remarkable recovery. It is imperative to diagnose VAP with multi-drug resistant strains as early as possible; colistin, the 'last resort' antibiotic, if instituted with proper monitoring at the right time, can be life saving.
Sujets)
Adolescent , Humains , Mâle , Infections à Acinetobacter/traitement médicamenteux , Antibactériens/usage thérapeutique , Colistine/usage thérapeutique , Pneumopathie infectieuse sous ventilation assistée/traitement médicamenteux , Infections à Pseudomonas/traitement médicamenteux , Infections à Acinetobacter/diagnostic , Multirésistance bactérienne aux médicaments , Pneumopathie infectieuse sous ventilation assistée/diagnostic , Pneumopathie infectieuse sous ventilation assistée/microbiologie , Infections à Pseudomonas/diagnostic , Résultat thérapeutiqueRésumé
Sino-orbital aspergillosis in a 61-year-old male with uncontrolled non-insulin dependent diabetes mellitus presented with three months history of left ear pain, left side headache with mucopurulent nasal discharge and one week history of progressive swelling and pain with difficulty in opening of the left eye and sudden loss of vision. In spite of surgical debridement and medical management with amphotericin B and itraconazole his visual outcome was poor and the infection was unabated at one month follow up.